In a significant addition to the Pensacola, Florida medical community, Ochsner Novant Health 65 Plus – Bellview has announced the welcoming of Dr. Brandon M. McElroy, a board-certified internal medicine physician with close to a decade of expertise in primary care.
In a groundbreaking advance that heralds a new era in pediatric oncology, researchers at St. Jude Children’s Research Hospital have unveiled a promising therapeutic strategy to combat neuroblastoma, a devastating childhood cancer notorious for its complexity and resistance to treatment.
Dr. Jianyang Du, an accomplished associate professor at the University of Tennessee Health Science Center, has recently been awarded a notable grant of $1.5 million from the National Institute of Mental Health.
Researchers are continuously striving to unravel the complexities of human biology, and recent advancements have brought them closer to this goal.
Immunotherapy, treatments that reinvigorate immune cells’ anti-cancer activity or reprogram T cells to target cancer, has shown promise in treating leukemias but has not yet been realized in solid tumors.
MYCN is a gene associated with cell proliferation and growth, which is mutated in many types of cancer. Scientists at St. Jude Children’s Research Hospital studying high-risk neuroblastoma found that MYCN plays a role in modifying the cellular state, causing a positive feedback loop that leads to a faster progressing disease.
St. Jude Children’s Research Hospital investigators collaborated with a global group of acute pediatric critical illness experts to reach a consensus definition of the condition.
A team of UTHSC researchers has been awarded $924,000 from the Department of Defense for their work developing a new treatment for ovarian cancer. The project is a collaboration between the labs of Wei Li, PhD, distinguished professor of Pharmaceutical Sciences and director of the Drug Discovery Center in the College of Pharmacy, Junming Yue,… Read More
